Skip to product information
1 of 1

Fenbendazole USP Powder 1000g

Fenbendazole USP Powder 1000g

Read reviews →
Also see: Amazon · Google · Reddit
Regular price $275.15 USD
Regular price Sale price $275.15 USD
Sale Sold out
Shipping calculated at checkout.
Quantity

The full picture

Everything Vyvata knows about this product — the score, the evidence, the FAQ, and where else to find shopper reviews. No hidden data. Every vendor is scored on the same published rubric — no brand can pay for placement. Read the rubric →

25/100
Rejected

Six-dimension breakdown

Evidence
15
Formulation
40
Manufacturing
45
Safety
20
Transparency
35
Sustainability
30

Why this scored 25/100

Fenbendazole is a veterinary benzimidazole anti-parasitic (Panacur brand for dogs/livestock) that has been popularized as an off-label cancer treatment via the "Joe Tippens protocol" — despite no human RCT evidence and only in-vitro / animal cancer signals (Dogra 2018 Sci Rep, mouse xenograft only). The FDA has never approved fenbendazole for human use; case reports of fenbendazole-associated severe hepatotoxicity in self-treating cancer patients have appeared (Chiba 2022 J Med Case Reports and similar). Bulk 1 kg powder sold to consumers without medical supervision creates severe risk of misuse and self-medication for serious disease. Autofailed as unverified_disease_claim regardless of listing copy — the SKU exists in this quantity for exactly one reason. Not a Vyvata-appropriate product under any stack framing.

Auto-fail rule triggered: Unverified disease claim.

The product markets a disease-treatment, -prevention, or -cure claim (memory loss, cardiovascular disease, cancer, etc.) without published double-blind RCT evidence at the label dose to support that claim. Under FDA and FTC guidance this level of claim requires drug-approval standards of evidence. See the full rubric →

Last scored: Full rubric →

Evidence & sources

The Vyvata score's Evidence dimension measures the quality of published RCT support for a product's active ingredients at the label dose. Our source hierarchy: double-blind RCTs in MEDLINE-indexed journals > single-blind RCTs > open-label trials > observational studies > mechanism papers > N=1 case studies (anecdotes). Predatory journals and manufacturer-authored studies without independent replication are weighted down.

Product-specific evidence citations for this item are embedded in the analysis text on the "Analysis" tab. For the full framework and evidence hierarchy, see the methodology page.

How to read the Evidence dimension

  • 80–100: Multiple double-blind RCTs in indexed journals directly testing this product OR the exact ingredients at the exact dose.
  • 60–79: Single double-blind RCT + supporting ingredient literature at the studied dose.
  • 40–59: Open-label trials + ingredient literature; no product-specific double-blind evidence.
  • 20–39: Ingredient literature only; no product-specific trials or trials in predatory venues.
  • 0–19: No credible evidence base or unverifiable claims.

Frequently asked questions

Auto-generated from Vyvata's scoring data for this product. For general questions about the store (shipping, returns, wholesale), see the site FAQ.

What is Fenbendazole USP Powder 1000g?

Fenbendazole USP Powder 1000g, categorized under Immune health & antioxidants in the Supplements vertical. It is scored on the Vyvata Scoring Framework — an independent 6-dimension rubric applied uniformly to every product Vyvata lists.

How does Fenbendazole USP Powder 1000g score on the Vyvata rubric?

25/100 overall — Rejected tier (0–49 band). Per-dimension breakdown: Manufacturing 45, Formulation 40, Transparency 35, Sustainability 30, Safety 20, Evidence 15. Scored as of 2026-08-24.

Why did Fenbendazole USP Powder 1000g score in the Rejected tier?

Fenbendazole is a veterinary benzimidazole anti-parasitic (Panacur brand for dogs/livestock) that has been popularized as an off-label cancer treatment via the "Joe Tippens protocol" — despite no human RCT evidence and only in-vitro / animal cancer signals (Dogra 2018 Sci Rep, mouse xenograft only). The FDA has never approved fenbendazole for human use; case reports of fenbendazole-associated severe hepatotoxicity in self-treating cancer patients have appeared (Chiba 2022 J Med Case Reports and similar). Bulk 1 kg powder sold to consumers without medical supervision creates severe risk of misuse and self-medication for serious disease. Autofailed as unverified_disease_claim regardless of listing copy — the SKU exists in this quantity for exactly one reason. Not a Vyvata-appropriate product under any stack framing.

What are the strongest and weakest aspects of this product?

Strongest: Manufacturing at 45/100 (third-party testing, GMP compliance, and facility audit status) and Formulation at 40/100 (dose adequacy, bioavailability form, and ingredient redundancy). Weakest: Safety at 20/100 (adverse-event profile, interaction risk, and dose ceiling) and Evidence at 15/100 (quality of published RCT support for the active ingredients at the label dose). All six dimensions feed the overall Vyvata score; a weakness on any one dimension pulls the overall down proportionally.

Is Fenbendazole USP Powder 1000g third-party tested?

No third-party certifications (NSF, USP, ConsumerLab, or equivalent) were on record at the time of scoring. This affects the Manufacturing dimension score. The manufacturer may test internally or have obtained certification more recently — check the current product label for the most up-to-date information.

Why was this product auto-rejected?

This product triggered the Vyvata auto-fail rule "unverified_disease_claim", which places it in the Rejected tier regardless of its scores on other dimensions. See the full explanation above and the methodology page for the current list of auto-fail rules.

Are there higher-scoring alternatives to Fenbendazole USP Powder 1000g?

The top-ranked immune health & antioxidants product in the Vyvata catalog is currently PreserVision AREDS 2 Eye Vitamins, 210 Soft gels at 77/100. See the full ranked list of 590 scored products in this subcategory at https://vyvata.com/pages/best-immune-health-and-antioxidants-supplements-ranked.

What does the Vyvata score mean?

The Vyvata Scoring Framework rates every listed product 0–100 across six dimensions: Evidence, Formulation, Manufacturing, Safety, Transparency, and Sustainability. Tier bands: Elite 85–100 (top-tier evidence + formulation + manufacturing), Verified 70–84 (strong on most dimensions), Standard 50–69 (solid but with weaknesses called out), Rejected 0–49 (specific failures documented). Rejected products remain listed with reasons. Full methodology at https://vyvata.com/pages/methodology.

Where can I read customer reviews for Fenbendazole USP Powder 1000g?

The Vyvata score measures product integrity against a published rubric, not customer sentiment. For customer reviews and community discussion, search external platforms directly: Amazon (https://www.amazon.com/s?k=Fenbendazole%20USP%20Powder%201000g),Google(https://www.google.com/search?q=Fenbendazole%20USP%20Powder%201000g+reviews),Reddit(https://www.reddit.com/search/?q=Fenbendazole%20USP%20Powder%201000g%20review),andTrustpilot(https://www.trustpilot.com/search?query=Fenbendazole%20USP%20Powder%201000g).Vyvatadoesnotaggregate,republish,orlicensethosethird-partyreviews.

Customer reviews

Reviews on other platforms

The Vyvata score measures product integrity against a published rubric, not customer sentiment. Vyvata does not aggregate, republish, or license third-party reviews — the links below open search pages on their respective platforms.

All the data we have on this product

Every VSF-related metafield surfaced verbatim. Nothing hidden. If you spot data that looks wrong, let us know.

VSF score
25 / 100
Tier
Rejected
Category
Supplements
Subcategory
immune antioxidants
Last scored
Auto-fail rule
unverified_disease_claim
Third-party certifications
None on record at time of scoring
Vendor
Pasteur Pharmacy
Product type
Pet Supplies
Tags
Pasteur Pharmacy, Shopify Collective

Every score is set from the published rubric, audit-logged, and rescored whenever new evidence emerges (published trials, updated labels, third-party testing releases). Every vendor is scored on the same criteria — no pay-to-play. See our editorial-independence disclosure for the full policy, including brands with an editorial relationship to this site.

View full details